Rate of recurrent neutropenia between the omitted of bolus dose of fluorouracil group compare with the oxaliplatin dose reduction group in colorectal cancer patients, a randomized cross-over trial
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2568181
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: an omitted of bolus dose of fluorouracil of modified FOLFOX6 regimen,reduction of oxaliplatin dose of modified FOLFOX6 regimen, from 85 to 65 milligram per square meter;Experimental Drug,Active Comparator Drug;an omitted of bolus dose of 5-FU group,an oxaliplatin reduction group
Primary outcome(s): rate of recurrent neutropenia within 2 cycles of chemotherapy (mFOLFOX6 regimen) rate
Study Design: Randomized
创建时间：
2019-07-15
